Desiree Sainthrope is a preeminent legal expert specializing in global compliance and trade agreements, with a career dedicated to navigating the complex intersection of regulatory oversight and institutional liability. Today, she joins us to unpack the unprecedented legal battle between the FTC
The tension between national deregulation and local conservation has reached a critical boiling point as Illinois attempts to solidify its own environmental standards against a backdrop of federal rollbacks. With Washington pivoting toward the removal of long-standing oversight on carbon emissions
The legal battle currently unfolding in federal court has placed a significant shadow over Illinois' aggressive efforts to curb the rising costs of prescription medications through strict oversight of pharmacy benefit managers. As the state implements the Healthcare Protection Act, a sweeping piece
The traditional notion of a medical regulator acting as a one-time gatekeeper is rapidly dissolving as the United Kingdom pioneers a sophisticated model focused on the entire lifecycle of artificial intelligence in clinical settings. This transition marks a fundamental departure from the legacy
The unanimous decision handed down by the Supreme Court in the high-stakes case of Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. represents a transformative moment for the pharmaceutical landscape and the broader application of patent law. This landmark ruling effectively safeguards the
The American Medical Association, long considered a bastion of professional stability and moderate advocacy, has suddenly found itself at the center of a political firestorm that threatens the very foundations of its institutional authority. With more than 320,000 physicians under its umbrella, the
